Published in Int Immunol on February 01, 1999
A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity (2005) 3.02
Murine neonatal CD4+ cells are poised for rapid Th2 effector-like function. J Immunol (2007) 1.41
A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell (2000) 17.61
The role of mononuclear phagocytes in HTLV-III/LAV infection. Science (1986) 17.33
Plasma cell differentiation requires the transcription factor XBP-1. Nature (2001) 9.72
Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA (1996) 9.45
Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity (1996) 8.16
Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science (1991) 7.25
B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell (1995) 6.88
Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature (1996) 6.23
Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell (1993) 5.99
Hybrid vigor, fetal overgrowth, and viability of mice derived by nuclear cloning and tetraploid embryo complementation. Proc Natl Acad Sci U S A (2001) 5.76
The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell (1996) 5.13
The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med (2002) 4.47
Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet (1995) 4.31
Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis. J Clin Invest (1967) 4.31
An essential role in liver development for transcription factor XBP-1. Genes Dev (2000) 4.17
Suppression of intestinal neoplasia by DNA hypomethylation. Cell (1995) 4.16
The transcription factor NF-ATc is essential for cardiac valve formation. Nature (1998) 4.14
Immunoglobulin E production in the absence of interleukin-4-secreting CD1-dependent cells. Science (1997) 3.92
The transcription factor c-Maf controls the production of interleukin-4 but not other Th2 cytokines. Immunity (1999) 3.61
DNA hypomethylation leads to elevated mutation rates. Nature (1998) 3.60
Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes. J Immunol (1998) 3.48
Specificity of C-reactive protein for choline phosphate residues of pneumococcal C-polysaccharide. Proc Soc Exp Biol Med (1971) 3.32
Germ-line passage is required for establishment of methylation and expression patterns of imprinted but not of nonimprinted genes. Genes Dev (1996) 3.29
Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. N Engl J Med (1995) 3.26
Mucosal T lymphocyte numbers are selectively reduced in integrin alpha E (CD103)-deficient mice. J Immunol (1999) 3.21
Hyperproliferation and dysregulation of IL-4 expression in NF-ATp-deficient mice. Immunity (1996) 3.05
The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis (1974) 3.01
Ia antigen-bearing B cell tumor lines can present protein antigen and alloantigen in a major histocompatibility complex-restricted fashion to antigen-reactive T cells. J Exp Med (1982) 3.01
Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med (1977) 2.92
A new member of the leucine zipper class of proteins that binds to the HLA DR alpha promoter. Science (1990) 2.83
CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science (1999) 2.60
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol (1999) 2.58
c-maf promotes T helper cell type 2 (Th2) and attenuates Th1 differentiation by both interleukin 4-dependent and -independent mechanisms. J Exp Med (1998) 2.58
Magnitude of response of histocompatibility-restricted T-cell clones is a function of the product of the concentrations of antigen and Ia molecules. Proc Natl Acad Sci U S A (1983) 2.57
Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science (1991) 2.56
Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature (1992) 2.55
Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature (1996) 2.50
Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis. J Exp Med (1999) 2.42
The biology of Stat4 and Stat6. Oncogene (2000) 2.40
Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity (1994) 2.40
Transcriptional regulation of Th1/Th2 polarization. Immunol Today (2000) 2.39
NFATc1 and NFATc2 together control both T and B cell activation and differentiation. Immunity (2001) 2.38
mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element. Mol Cell Biol (1990) 2.38
Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer (1974) 2.36
Generation of mice from wild-type and targeted ES cells by nuclear cloning. Nat Genet (2000) 2.36
Malarial antibodies and autoantibodies to heart and other tissues in the immigrant and indigenous peoples of Uganda. Lancet (1968) 2.35
A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol (2000) 2.33
Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med (1998) 2.28
Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol (1998) 2.20
Effect of targeted disruption of STAT4 and STAT6 on the induction of experimental autoimmune encephalomyelitis. J Clin Invest (2001) 2.19
The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev (1995) 2.19
Mice lacking major histocompatibility complex class I and class II molecules. Proc Natl Acad Sci U S A (1993) 2.18
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science (1988) 2.17
Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity (1998) 2.16
The transcription factor NFAT4 is involved in the generation and survival of T cells. Immunity (1998) 2.13
In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science (1991) 2.02
Delayed lymphoid repopulation with defects in IL-4-driven responses produced by inactivation of NF-ATc. Immunity (1998) 2.00
1,25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol (1984) 1.97
Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J Exp Med (1996) 1.95
Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol Cell Biol (1995) 1.89
The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.86
Interleukin-10 is an autocrine growth factor for acquired immunodeficiency syndrome-related B-cell lymphoma. Blood (1995) 1.84
The basic domain/leucine zipper protein hXBP-1 preferentially binds to and transactivates CRE-like sequences containing an ACGT core. Nucleic Acids Res (1996) 1.83
Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity (1995) 1.82
Chondrodysplasia and neurological abnormalities in ATF-2-deficient mice. Nature (1996) 1.82
Autoimmunity to the heart in cardiac disease. Current concepts of the relation of autoimmunity to rheumatic fever, postcardiotomyand postinfarction syndromes and cardiomyopathies. Am J Cardiol (1969) 1.79
MHC class II, antigen presentation and tumor necrosis factor in renal tubular epithelial cells. Kidney Int (1990) 1.77
IA mutant functional antigen-presenting cell lines. J Immunol (1983) 1.76
Staphylococcus epidermidis extracted slime inhibits the antimicrobial action of glycopeptide antibiotics. J Infect Dis (1990) 1.75
Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity (2000) 1.74
A QUANTITATIVE STUDY OF THE FIBRINOLYSIN-ANTIFIBRINOLYSIN REACTION. Science (1945) 1.74
Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci U S A (1993) 1.72
Antigen presentation abrogated in cells expressing truncated Ia molecules. J Immunol (1989) 1.71
Isolation and characterization of the Lyme disease spirochete from the skin of patients with erythema chronicum migrans. J Am Acad Dermatol (1985) 1.71
Production of autoreactive I region-restricted T cell hybridomas. J Exp Med (1982) 1.70
Autoreactive CD4+ T cells protect from autoimmune diabetes via bystander suppression using the IL-4/Stat6 pathway. Immunity (1999) 1.69
Fatal adenovirus disease and human immunodeficiency virus infection. Pediatr Infect Dis J (1990) 1.69
Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q. J Immunol (1974) 1.68
Rapid detection of respiratory syncytial virus in nasopharyngeal aspirates by a commercial enzyme immunoassay. J Clin Microbiol (1986) 1.67
In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum (1991) 1.66
Th1 and Th2 mediate acute graft-versus-host disease, each with distinct end-organ targets. J Clin Invest (2000) 1.65
Murine syngeneic mixed lymphocyte response. I. Target antigens are self Ia molecules. J Exp Med (1981) 1.65
The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J Exp Med (2000) 1.63
Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci U S A (1993) 1.61
Clinical and serological features of human herpesvirus-6 infection in three adults. Lancet (1988) 1.61
Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice. J Exp Med (1994) 1.61